Medical Image Analysis Software Market By Type (Integrated, Stand-alone), By Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Combined Modalities, Others), By Application (Orthopedic, Dental, Neurology, Cardiology, Oncology, Others), By End User (Hospitals, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2022-2031

Medical Image Analysis Software Market

Medical image analysis is the process of extracting meaningful information from medical images, often using computational methods. The medical image analysis procedure includes the tasks like visualization and exploration of 2D images and 3D volumes, segmentation, classification, registration, and 3D reconstruction of image data. The images for this analysis can be obtained from medical imaging modalities such as x-ray (2D and 3D), ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), nuclear imaging (PET and SPECT), and microscopy.

Key factors driving the growth of the medical image analysis software market include the rise in the geriatric population and growing adoption of medical imaging systems to facilitate faster diagnosis of chronic diseases. Moreover, increasing incidence of chronic diseases, rise in demand for health care services for the aging population and continuous developments in the field of imaging technology, such as computer-aided diagnosis (CAD) are expected to notably contribute toward the market growth. Furthermore, the global medical image analysis software market growth is largely driven by factors such as an increase in advancements of medical imaging software is expected to surely lead to the growth of the market. Prominent players in the global medical image analysis software market have opted various strategies such as product launch, acquisition, and investments in R&D for advancement in medical image analysis software to strengthen their position in the market and sustain the competitive environment. A significant increase in awareness about the advantages of medical imaging software products and increase in the usage of software in medical imaging and rise in the number of patients suffering from diseases are some of the key factors driving the growth of the market.

However, the security risks of data stored concerns and high installation cost and maintenance hamper restricts the market growth. Conversely, the introduction of Artificial Intelligence (AI) in medical imaging has changed the market dynamics in the forecast period and is expected to provide lucrative opportunities for the growth of the market. Extensive R&D activities in the field of medical imaging along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market.

The global medical image analysis software market is segmented based on type, modality, application, end user and region. On the basis of type, the market is classified into integrated and standalone. On the basis of modalities, the market is classified into computed tomography, magnetic resonance imaging, ultrasound, combined modalities and others. On the basis of application, the market is classified into orthopedic, dental, neurology, cardiology, oncology and others. On the basis of end user, the market is classified into hospitals, diagnostic centers and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

The key players profiled in the study include IBM Corporation, Canon Medical Systems Corporation, Siemens Healthineers, ESAOTE SPA, Coexya, MIM Software Inc., Koninklijke Philips N.V., GE Healthcare, Spacelabs Healthcare, Agfa Healthcare. The players in the market have been actively engaged in the adoption various strategies such as acquisition, product launch, partnership, product approval and product development to remain competitive and gain an advantage over the competitors in the market. For instance, in August 2022, Royal Philips announced that U.S. Food and Drug Administration has given the 510 (k) clearance for its Philips SmartCT application software. SmartCT is a key component of Philips Image Guided Therapy System – Azurion – providing interventionalists with CT-like 3D images (Cone Beam CT) to support diagnosis, therapy planning, treatment and follow-up for interventional radiology procedures.                                                                                                                                        

Key Market Insights (Updated)

By type, the integrated segment was the highest revenue contributor to the market and is estimated to continue this during the analysis period, with a CAGR of 12.1%. However, the standalone segment is estimated to be the fastest-growing segment with a CAGR of 12.8% during the forecast period.

By modality, the computed tomography segment was the highest revenue contributor to the market and is estimated to continue this during the analysis period, with a CAGR of 12.1%. However, the magnetic resonance imaging segment is estimated to be the fastest-growing segment with a CAGR of 13.4% during the forecast period.

By application, the cardiology segment was the highest revenue contributor to the market and is estimated to continue this during the analysis period, with a CAGR of 12.0%. However, the dental segment is estimated to be the fastest-growing segment with a CAGR of 13.4% during the forecast period.

By end user, the hospitals segment was the highest revenue contributor to the market and is estimated to continue this during the analysis period, with a CAGR of 12.5%. Moreover, the hospitals segment is estimated to be the fastest-growing segment with a CAGR of 12.5% during the forecast period.

Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 13.5% during the forecast period.

Overview

The medical image analysis software market was valued at $3.9 billion in 2021 and is projected to reach $12.3 billion by 2031, registering a CAGR of 12.2% from 2022 to 2031.  

The application of medical image analysis software enables quantitative analysis and visualization of medical images of numerous modalities such as PET, MRI, CT, or microscopy. The applications of enabling both manual and automated analysis of 3D medical images unlocks various opportunities to the benefit of providers and patients. It includes machine learning systems to facilitate early diagnostics for higher cure and survival rates, neural networks for diagnosis validation, research-specific algorithms to find hidden patterns and valuable insights to improve drug development. It may also include the examination of complex imaging types with adverse symptoms segmentation solutions to pinpoint a treatment area and thus minimizing possible damage to healthy tissue during an invasive procedure, applications integrating 3D imaging with virtual reality (VR) devices to enable immersive training of health specialists, patient education, and advanced diagnostics. Integrating advanced technologies into the image interpretation pipeline can help the healthcare sector address challenges associated with large amounts of data. Custom software development of medical image analysis tools is a critical step in this process. 

The growth of the medical image analysis software market is driven by increasing incidence of chronic diseases, rise in demand for health care services for the aging population, and continuous developments in the field of imaging technology, such as computer-aided diagnosis (CAD). Moreover, the rise in the geriatric population and growing adoption of ultrasound imaging systems to facilitate faster diagnosis of chronic diseases is expected to notably contribute toward the market growth. Furthermore, the global medical image analysis software market growth is largely driven by factors such as an increase in advancements of medical imaging software which is expected to lead to the growth of the market. Prominent players in the global medical image analysis software market have opted various strategies such as product launch, acquisition, and investments in R&D for advancement in medical image analysis software to strengthen their position in the market and sustain the competitive environment.  

A significant increase in awareness about the advantages of medical imaging software products, rise in the usage of software in medical imaging, and surge in the number of patients suffering from diseases are some of the key factors driving the growth of the market. However, the security risks of data stored concerns and high installation cost and maintenance hamper the market growth. Conversely, introduction of Artificial Intelligence (AI) in medical imaging has changed the market dynamics in the forecast period which is expected to provide lucrative opportunities for the growth of the market. Extensive R&D activities in the field of medical imaging along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market. 

The global medical image analysis software market is segmented based on type, modality, imaging type, application, end user, and region. On the basis of type, the market is classified into integrated and standalone. As per modalities, the market is classified into tomography, ultrasound imaging, radiographic imaging, and combined modalities. According to imaging type, the market is classified into 2D imaging, 3D imaging, and 4D imaging. Depending on application, the market is classified into orthopedic, dental, neurology, cardiology, oncology, obstetrics & gynecology, and others. By end user, the market is classified into hospitals, diagnostic centers, ambulatory surgical centers, and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major companies profiled in the report include Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Spacelabs Healthcare, Agfa-Gevaert Group, MIM Software, Inc., Toshiba Medical Systems Corporation, ESAOTE SPA, Merge Healthcare, Inc., and Aquilab SAS. 

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical image analysis software market analysis from 2021 to 2031 to identify the prevailing medical image analysis software market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the medical image analysis software market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global medical image analysis software market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Agfa Healthcar

Scope of Medical Image Analysis Software Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of suppliers

3.3.2. Bargaining power of buyers

3.3.3. Threat of substitutes

3.3.4. Threat of new entrants

3.3.5. Intensity of rivalry

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in the prevalence of chronic diseases

3.4.1.2. Rise in developments in the field of imaging technology

3.4.1.3. Increase in usage in medical applications

3.4.2. Restraints

3.4.2.1. High security risks of data stored

3.4.3. Opportunities

3.4.3.1. Introduction of Artificial Intelligence (AI) in medical imaging

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Integrated

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Stand-alone

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Computed Tomography

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Magnetic Resonance Imaging

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Ultrasound

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

5.5. Combined Modalities

5.5.1. Key market trends, growth factors and opportunities

5.5.2. Market size and forecast, by region

5.5.3. Market share analysis by country

5.6. Others

5.6.1. Key market trends, growth factors and opportunities

5.6.2. Market size and forecast, by region

5.6.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Orthopedic

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Dental

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Neurology

6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

6.5. Cardiology

6.5.1. Key market trends, growth factors and opportunities

6.5.2. Market size and forecast, by region

6.5.3. Market share analysis by country

6.6. Oncology

6.6.1. Key market trends, growth factors and opportunities

6.6.2. Market size and forecast, by region

6.6.3. Market share analysis by country

6.7. Others

6.7.1. Key market trends, growth factors and opportunities

6.7.2. Market size and forecast, by region

6.7.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast

7.2. Hospitals

7.2.1. Key market trends, growth factors and opportunities

7.2.2. Market size and forecast, by region

7.2.3. Market share analysis by country

7.3. Diagnostic Centers

7.3.1. Key market trends, growth factors and opportunities

7.3.2. Market size and forecast, by region

7.3.3. Market share analysis by country

7.4. Others

7.4.1. Key market trends, growth factors and opportunities

7.4.2. Market size and forecast, by region

7.4.3. Market share analysis by country

8.1. Overview

8.1.1. Market size and forecast By Region

8.2. North America

8.2.1. Key trends and opportunities

8.2.2. Market size and forecast, by Type

8.2.3. Market size and forecast, by Modality

8.2.4. Market size and forecast, by Application

8.2.5. Market size and forecast, by End User

8.2.6. Market size and forecast, by country

8.2.6.1. U.S.

8.2.6.1.1. Key market trends, growth factors and opportunities

8.2.6.1.2. Market size and forecast, by Type

8.2.6.1.3. Market size and forecast, by Modality

8.2.6.1.4. Market size and forecast, by Application

8.2.6.1.5. Market size and forecast, by End User

8.2.6.2. Canada

8.2.6.2.1. Key market trends, growth factors and opportunities

8.2.6.2.2. Market size and forecast, by Type

8.2.6.2.3. Market size and forecast, by Modality

8.2.6.2.4. Market size and forecast, by Application

8.2.6.2.5. Market size and forecast, by End User

8.2.6.3. Mexico

8.2.6.3.1. Key market trends, growth factors and opportunities

8.2.6.3.2. Market size and forecast, by Type

8.2.6.3.3. Market size and forecast, by Modality

8.2.6.3.4. Market size and forecast, by Application

8.2.6.3.5. Market size and forecast, by End User

8.3. Europe

8.3.1. Key trends and opportunities

8.3.2. Market size and forecast, by Type

8.3.3. Market size and forecast, by Modality

8.3.4. Market size and forecast, by Application

8.3.5. Market size and forecast, by End User

8.3.6. Market size and forecast, by country

8.3.6.1. Germany

8.3.6.1.1. Key market trends, growth factors and opportunities

8.3.6.1.2. Market size and forecast, by Type

8.3.6.1.3. Market size and forecast, by Modality

8.3.6.1.4. Market size and forecast, by Application

8.3.6.1.5. Market size and forecast, by End User

8.3.6.2. France

8.3.6.2.1. Key market trends, growth factors and opportunities

8.3.6.2.2. Market size and forecast, by Type

8.3.6.2.3. Market size and forecast, by Modality

8.3.6.2.4. Market size and forecast, by Application

8.3.6.2.5. Market size and forecast, by End User

8.3.6.3. UK

8.3.6.3.1. Key market trends, growth factors and opportunities

8.3.6.3.2. Market size and forecast, by Type

8.3.6.3.3. Market size and forecast, by Modality

8.3.6.3.4. Market size and forecast, by Application

8.3.6.3.5. Market size and forecast, by End User

8.3.6.4. Italy

8.3.6.4.1. Key market trends, growth factors and opportunities

8.3.6.4.2. Market size and forecast, by Type

8.3.6.4.3. Market size and forecast, by Modality

8.3.6.4.4. Market size and forecast, by Application

8.3.6.4.5. Market size and forecast, by End User

8.3.6.5. Spain

8.3.6.5.1. Key market trends, growth factors and opportunities

8.3.6.5.2. Market size and forecast, by Type

8.3.6.5.3. Market size and forecast, by Modality

8.3.6.5.4. Market size and forecast, by Application

8.3.6.5.5. Market size and forecast, by End User

8.3.6.6. Rest of Europe

8.3.6.6.1. Key market trends, growth factors and opportunities

8.3.6.6.2. Market size and forecast, by Type

8.3.6.6.3. Market size and forecast, by Modality

8.3.6.6.4. Market size and forecast, by Application

8.3.6.6.5. Market size and forecast, by End User

8.4. Asia-Pacific

8.4.1. Key trends and opportunities

8.4.2. Market size and forecast, by Type

8.4.3. Market size and forecast, by Modality

8.4.4. Market size and forecast, by Application

8.4.5. Market size and forecast, by End User

8.4.6. Market size and forecast, by country

8.4.6.1. China

8.4.6.1.1. Key market trends, growth factors and opportunities

8.4.6.1.2. Market size and forecast, by Type

8.4.6.1.3. Market size and forecast, by Modality

8.4.6.1.4. Market size and forecast, by Application

8.4.6.1.5. Market size and forecast, by End User

8.4.6.2. Japan

8.4.6.2.1. Key market trends, growth factors and opportunities

8.4.6.2.2. Market size and forecast, by Type

8.4.6.2.3. Market size and forecast, by Modality

8.4.6.2.4. Market size and forecast, by Application

8.4.6.2.5. Market size and forecast, by End User

8.4.6.3. India

8.4.6.3.1. Key market trends, growth factors and opportunities

8.4.6.3.2. Market size and forecast, by Type

8.4.6.3.3. Market size and forecast, by Modality

8.4.6.3.4. Market size and forecast, by Application

8.4.6.3.5. Market size and forecast, by End User

8.4.6.4. Australia

8.4.6.4.1. Key market trends, growth factors and opportunities

8.4.6.4.2. Market size and forecast, by Type

8.4.6.4.3. Market size and forecast, by Modality

8.4.6.4.4. Market size and forecast, by Application

8.4.6.4.5. Market size and forecast, by End User

8.4.6.5. South Korea

8.4.6.5.1. Key market trends, growth factors and opportunities

8.4.6.5.2. Market size and forecast, by Type

8.4.6.5.3. Market size and forecast, by Modality

8.4.6.5.4. Market size and forecast, by Application

8.4.6.5.5. Market size and forecast, by End User

8.4.6.6. Rest of Asia-Pacific

8.4.6.6.1. Key market trends, growth factors and opportunities

8.4.6.6.2. Market size and forecast, by Type

8.4.6.6.3. Market size and forecast, by Modality

8.4.6.6.4. Market size and forecast, by Application

8.4.6.6.5. Market size and forecast, by End User

8.5. LAMEA

8.5.1. Key trends and opportunities

8.5.2. Market size and forecast, by Type

8.5.3. Market size and forecast, by Modality

8.5.4. Market size and forecast, by Application

8.5.5. Market size and forecast, by End User

8.5.6. Market size and forecast, by country

8.5.6.1. Brazil

8.5.6.1.1. Key market trends, growth factors and opportunities

8.5.6.1.2. Market size and forecast, by Type

8.5.6.1.3. Market size and forecast, by Modality

8.5.6.1.4. Market size and forecast, by Application

8.5.6.1.5. Market size and forecast, by End User

8.5.6.2. Saudi Arabia

8.5.6.2.1. Key market trends, growth factors and opportunities

8.5.6.2.2. Market size and forecast, by Type

8.5.6.2.3. Market size and forecast, by Modality

8.5.6.2.4. Market size and forecast, by Application

8.5.6.2.5. Market size and forecast, by End User

8.5.6.3. South Africa

8.5.6.3.1. Key market trends, growth factors and opportunities

8.5.6.3.2. Market size and forecast, by Type

8.5.6.3.3. Market size and forecast, by Modality

8.5.6.3.4. Market size and forecast, by Application

8.5.6.3.5. Market size and forecast, by End User

8.5.6.4. Rest of LAMEA

8.5.6.4.1. Key market trends, growth factors and opportunities

8.5.6.4.2. Market size and forecast, by Type

8.5.6.4.3. Market size and forecast, by Modality

8.5.6.4.4. Market size and forecast, by Application

8.5.6.4.5. Market size and forecast, by End User

9.1. Introduction

9.2. Top winning strategies

9.3. Product Mapping of Top 10 Player

9.4. Competitive Dashboard

9.5. Competitive Heatmap

9.6. Top player positioning, 2021

10.1. Agfa Healthcare

10.1.1. Company overview

10.1.2. Key Executives

10.1.3. Company snapshot

10.1.4. Operating business segments

10.1.5. Product portfolio

10.1.6. Business performance

10.1.7. Key strategic moves and developments

10.2. CANON MEDICAL SYSTEMS CORPORATION

10.2.1. Company overview

10.2.2. Key Executives

10.2.3. Company snapshot

10.2.4. Operating business segments

10.2.5. Product portfolio

10.2.6. Business performance

10.2.7. Key strategic moves and developments

10.3. Coexya

10.3.1. Company overview

10.3.2. Key Executives

10.3.3. Company snapshot

10.3.4. Operating business segments

10.3.5. Product portfolio

10.3.6. Key strategic moves and developments

10.4. ESAOTE SPA

10.4.1. Company overview

10.4.2. Key Executives

10.4.3. Company snapshot

10.4.4. Operating business segments

10.4.5. Product portfolio

10.5. GE Healthcare

10.5.1. Company overview

10.5.2. Key Executives

10.5.3. Company snapshot

10.5.4. Operating business segments

10.5.5. Product portfolio

10.5.6. Business performance

10.6. IBM Corporation

10.6.1. Company overview

10.6.2. Key Executives

10.6.3. Company snapshot

10.6.4. Operating business segments

10.6.5. Product portfolio

10.6.6. Business performance

10.7. Koninklijke Philips N.V.

10.7.1. Company overview

10.7.2. Key Executives

10.7.3. Company snapshot

10.7.4. Operating business segments

10.7.5. Product portfolio

10.7.6. Business performance

10.8. MIM Software, Inc

10.8.1. Company overview

10.8.2. Key Executives

10.8.3. Company snapshot

10.8.4. Operating business segments

10.8.5. Product portfolio

10.9. Siemens Healthineers

10.9.1. Company overview

10.9.2. Key Executives

10.9.3. Company snapshot

10.9.4. Operating business segments

10.9.5. Product portfolio

10.9.6. Business performance

10.9.7. Key strategic moves and developments

10.10. Spacelabs Healthcare

10.10.1. Company overview

10.10.2. Key Executives

10.10.3. Company snapshot

10.10.4. Operating business segments

10.10.5. Product portfoli

LIST OF TABLES

TABLE 01. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 02. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR INTEGRATED, BY REGION, 2021-2031 ($MILLION)

TABLE 03. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR STAND-ALONE, BY REGION, 2021-2031 ($MILLION)

TABLE 04. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 05. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2021-2031 ($MILLION)

TABLE 06. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2021-2031 ($MILLION)

TABLE 07. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND, BY REGION, 2021-2031 ($MILLION)

TABLE 08. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED MODALITIES, BY REGION, 2021-2031 ($MILLION)

TABLE 09. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 10. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 11. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ORTHOPEDIC, BY REGION, 2021-2031 ($MILLION)

TABLE 12. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DENTAL, BY REGION, 2021-2031 ($MILLION)

TABLE 13. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NEUROLOGY, BY REGION, 2021-2031 ($MILLION)

TABLE 14. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CARDIOLOGY, BY REGION, 2021-2031 ($MILLION)

TABLE 15. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ONCOLOGY, BY REGION, 2021-2031 ($MILLION)

TABLE 16. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 17. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 18. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 19. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021-2031 ($MILLION)

TABLE 20. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 21. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 22. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 23. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 24. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 25. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 26. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 27. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 28. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 29. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 30. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 31. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 32. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 33. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 34. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 35. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 36. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 37. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 38. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 39. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 40. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 41. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 42. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 43. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 44. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 45. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 46. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 47. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 48. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 49. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 50. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 51. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 52. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 53. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 54. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 55. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 56. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 57. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 58. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 59. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 60. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 61. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 62. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 63. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 64. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 65. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 66. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 67. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 68. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 69. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 70. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 71. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 72. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 73. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 74. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 75. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 76. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 77. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 78. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 79. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 80. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 81. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 82. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 83. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 84. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 85. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 86. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 87. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 88. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 89. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 90. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 91. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 92. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 93. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 94. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 95. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 96. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 97. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 98. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 99. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 100. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 101. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 102. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 103. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 104. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 105. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 106. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 107. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 108. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 109. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 110. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 111. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 112. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 113. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 114. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 115. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)

TABLE 116. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 117. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 118. AGFA HEALTHCARE: KEY EXECUTIVES

TABLE 119. AGFA HEALTHCARE: COMPANY SNAPSHOT

TABLE 120. AGFA HEALTHCARE: PRODUCT SEGMENTS

TABLE 121. AGFA HEALTHCARE: PRODUCT PORTFOLIO

TABLE 122. AGFA HEALTHCARE: KEY STRATERGIES

TABLE 123. CANON MEDICAL SYSTEMS CORPORATION: KEY EXECUTIVES

TABLE 124. CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT

TABLE 125. CANON MEDICAL SYSTEMS CORPORATION: PRODUCT SEGMENTS

TABLE 126. CANON MEDICAL SYSTEMS CORPORATION: PRODUCT PORTFOLIO

TABLE 127. CANON MEDICAL SYSTEMS CORPORATION: KEY STRATERGIES

TABLE 128. COEXYA: KEY EXECUTIVES

TABLE 129. COEXYA: COMPANY SNAPSHOT

TABLE 130. COEXYA: PRODUCT SEGMENTS

TABLE 131. COEXYA: PRODUCT PORTFOLIO

TABLE 132. COEXYA: KEY STRATERGIES

TABLE 133. ESAOTE SPA : KEY EXECUTIVES

TABLE 134. ESAOTE SPA : COMPANY SNAPSHOT

TABLE 135. ESAOTE SPA : PRODUCT SEGMENTS

TABLE 136. ESAOTE SPA : PRODUCT PORTFOLIO

TABLE 137. GE HEALTHCARE: KEY EXECUTIVES

TABLE 138. GE HEALTHCARE: COMPANY SNAPSHOT

TABLE 139. GE HEALTHCARE: SERVICE SEGMENTS

TABLE 140. GE HEALTHCARE: PRODUCT PORTFOLIO

TABLE 141. IBM CORPORATION: KEY EXECUTIVES

TABLE 142. IBM CORPORATION: COMPANY SNAPSHOT

TABLE 143. IBM CORPORATION: SERVICE SEGMENTS

TABLE 144. IBM CORPORATION: PRODUCT PORTFOLIO

TABLE 145. KONINKLIJKE PHILIPS N.V. : KEY EXECUTIVES

TABLE 146. KONINKLIJKE PHILIPS N.V. : COMPANY SNAPSHOT

TABLE 147. KONINKLIJKE PHILIPS N.V. : SERVICE SEGMENTS

TABLE 148. KONINKLIJKE PHILIPS N.V. : PRODUCT PORTFOLIO

TABLE 149. MIM SOFTWARE, INC: KEY EXECUTIVES

TABLE 150. MIM SOFTWARE, INC: COMPANY SNAPSHOT

TABLE 151. MIM SOFTWARE, INC: PRODUCT SEGMENTS

TABLE 152. MIM SOFTWARE, INC: PRODUCT PORTFOLIO

TABLE 153. SIEMENS HEALTHINEERS: KEY EXECUTIVES

TABLE 154. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT

TABLE 155. SIEMENS HEALTHINEERS: PRODUCT SEGMENTS

TABLE 156. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO

TABLE 157. SIEMENS HEALTHINEERS: KEY STRATERGIES

TABLE 158. SPACELABS HEALTHCARE: KEY EXECUTIVES

TABLE 159. SPACELABS HEALTHCARE: COMPANY SNAPSHOT

TABLE 160. SPACELABS HEALTHCARE: PRODUCT SEGMENTS

TABLE 161. SPACELABS HEALTHCARE: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (2022-2031)

FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS

FIGURE 05. MODERATE BARGAINING POWER OF BUYERS

FIGURE 06. MODERATE THREAT OF SUBSTITUTES

FIGURE 07. MODERATE THREAT OF NEW ENTRANTS

FIGURE 08. MODERATE INTENSITY OF RIVALRY

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALMEDICAL IMAGE ANALYSIS SOFTWARE MARKET

FIGURE 10. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR INTEGRATED, BY COUNTRY 2021-2031(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR STAND-ALONE, BY COUNTRY 2021-2031(%)

FIGURE 13. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY 2021-2031(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING, BY COUNTRY 2021-2031(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND, BY COUNTRY 2021-2031(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED MODALITIES, BY COUNTRY 2021-2031(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)

FIGURE 19. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021(%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ORTHOPEDIC, BY COUNTRY 2021-2031(%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DENTAL, BY COUNTRY 2021-2031(%)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NEUROLOGY, BY COUNTRY 2021-2031(%)

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CARDIOLOGY, BY COUNTRY 2021-2031(%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ONCOLOGY, BY COUNTRY 2021-2031(%)

FIGURE 25. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)

FIGURE 26. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021(%)

FIGURE 27. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)

FIGURE 28. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY 2021-2031(%)

FIGURE 29. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)

FIGURE 30. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET BY REGION, 2021

FIGURE 31. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 32. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 33. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 34. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 35. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 36. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 37. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 38. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 39. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 40. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 41. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 42. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 43. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 44. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 45. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 46. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 47. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 48. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 49. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)

FIGURE 50. TOP WINNING STRATEGIES, BY YEAR

FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 54. COMPETITIVE DASHBOARD

FIGURE 55. COMPETITIVE HEATMAP: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET

FIGURE 56. TOP PLAYER POSITIONING, 2021

FIGURE 57. AGFA HEALTHCARE: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 58. AGFA HEALTHCARE: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 59. AGFA HEALTHCARE: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 60. CANON MEDICAL SYSTEMS CORPORATION: NET SALES, 2019-2021 ($MILLION)

FIGURE 61. CANON MEDICAL SYSTEMS CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 62. CANON MEDICAL SYSTEMS CORPORATION: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 63. GE HEALTHCARE: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 64. GE HEALTHCARE: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021 ($MILLION)

FIGURE 65. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 66. GE HEALTHCARE: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 67. IBM CORPORATION: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 68. IBM CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021

FIGURE 69. IBM CORPORATION: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 70. IBM CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 71. KONINKLIJKE PHILIPS N.V. : NET REVENUE, 2019-2021 ($MILLION)

FIGURE 72. KONINKLIJKE PHILIPS N.V. : RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021

FIGURE 73. KONINKLIJKE PHILIPS N.V. : REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 74. KONINKLIJKE PHILIPS N.V. : REVENUE SHARE BY REGION, 2021 (%)

FIGURE 75. SIEMENS HEALTHINEERS: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 76. SIEMENS HEALTHINEERS: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 77. SIEMENS HEALTHINEERS: REVENUE SHARE BY REGION, 2021 (%